Detalhe da pesquisa
1.
Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis.
Mult Scler
; 26(7): 843-854, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297826
2.
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
Mult Scler
; 26(3): 312-321, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741108
3.
Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.
Mult Scler
; 26(7): 815-828, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31094280
4.
Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.
Brain
; 141(11): 3115-3129, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312381
5.
Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies.
Adv Radiat Oncol
; 8(4): 101191, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37213483
6.
Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
Neurology
; 96(20): e2525-e2533, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827962
7.
Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
Neurology
; 96(16): e2058-e2069, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653904